Mujahed Dalain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mujahed Dalain has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Abdulrahman Al-Dawoudi
Faculty of Medicine and Life Sciences University of Latvia Riga Latvia
6 shared publications - Daniil Varlamov
Faculty of Medicine and Life Sciences University of Latvia Riga Latvia
6 shared publications - Davis Freimanis
Faculty of Medicine and Life Sciences University of Latvia Riga Latvia
3 shared publications - Nazar Kopytko
Affiliation Medical Faculty 1, Poltava State Medical University, Poltava, Ukraine
3 shared publications - Shaghaf Alhallak
Faculty of Medicine Homs University Homs Syrian Arab Republic
3 shared publications Aiga Staka
Affiliations Faculty of Medicine and Life Sciences, University of Latvia, Riga, Latvia, Department of Gastroenterology, Pauls Stradins Clinical University Hospital, Riga, Latvia
2 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (11)
Immersive Virtual Reality Exposure Associated With a Migraine With Brainstem Aura–Like Presentation and Prolonged Recovery: A Case Report
Immersive virtual reality (VR) exposure can produce a range of neurological symptoms, but its possible relationship with prolonged migraine‐related symptoms remains poorly characterized. We report a 32‐year‐old male who developed acute disorientation, vertigo, cognitive clouding, derealization, and sensory disturbances immediately following a 30‐min immersive VR session. Symptoms partially improved but recurred with sensory overstimulation the following day. Despite unremarkable neuro‐otological examinations, the patient experienced a markedly atypical, two‐week period of persistent neurological symptoms featuring hypersomnia, cognitive fatigue, and sensory hypersensitivity. The presentation was considered a migraine with brainstem aura–like presentation, although it did not fulfill ICHD‐3 criteria for definite migraine with brainstem aura. Symptoms gradually resolved completely by approximately 2 weeks, with no recurrence reported at the 3‐ and 6‐month follow‐ups. This case describes a temporal association between immersive VR exposure and a prolonged migraine‐like neurological presentation, highlighting the need for clinical awareness of symptoms occurring after immersive digital exposure.
- 6 November 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (11)
Open AccessImmersive Virtual Reality Exposure Associated With a Migraine With Brainstem Aura–Like Presentation and Prolonged Recovery: A Case Report
Immersive virtual reality (VR) exposure can produce a range of neurological symptoms, but its possible relationship with prolonged migraine‐related symptoms remains poorly characterized. We report a 32‐year‐old male who developed acute disorientation, vertigo, cognitive clouding, derealization, and sensory disturbances immediately following a 30‐min immersive VR session. Symptoms partially improved but recurred with sensory overstimulation the following day. Despite unremarkable neuro‐otological examinations, the patient experienced a markedly atypical, two‐week period of persistent neurological symptoms featuring hypersomnia, cognitive fatigue, and sensory hypersensitivity. The presentation was considered a migraine with brainstem aura–like presentation, although it did not fulfill ICHD‐3 criteria for definite migraine with brainstem aura. Symptoms gradually resolved completely by approximately 2 weeks, with no recurrence reported at the 3‐ and 6‐month follow‐ups. This case describes a temporal association between immersive VR exposure and a prolonged migraine‐like neurological presentation, highlighting the need for clinical awareness of symptoms occurring after immersive digital exposure.
- Open Access
- 5 August 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (8) , e73304
Delayed Recognition of Thrombotic Thrombocytopenic Purpura Following Platelet Transfusion: A Clinical Pitfall
Thrombotic thrombocytopenic purpura (TTP) is a rare, life‐threatening thrombotic microangiopathy caused by severe ADAMTS13 deficiency, usually due to autoantibody‐mediated inhibition. Its presentation is heterogeneous and often lacks the classic pentad, leading to diagnostic delays. Neurological symptoms may predominate, masking the underlying hematologic emergency. In our case, a 37‐year‐old previously healthy woman presented with acute headache, speech disturbance, and altered mental status. Despite normal neuroimaging, laboratory tests revealed severe thrombocytopenia and normocytic anemia. Lack of response to erythrocyte and platelet transfusions prompted further evaluation, revealing microangiopathic hemolytic anemia with elevated lactate dehydrogenase, undetectable haptoglobin, indirect hyperbilirubinemia, reticulocytosis, and normal coagulation parameters. A PLASMIC score of 6/7 indicated a high probability of severe ADAMTS13 deficiency. Treatment with high‐dose corticosteroids was initiated immediately, followed by plasma exchange and rituximab. ADAMTS13 activity confirmed severe deficiency at 0.3%, supporting the diagnosis of acquired TTP in the clinical context. The patient achieved rapid remission and complete neurological recovery. This case highlights the importance of early recognition of microangiopathic hemolysis and prompt treatment without waiting for confirmatory ADAMTS13 results to reduce morbidity and mortality.
- 5 August 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (8) , e73304
Open AccessDelayed Recognition of Thrombotic Thrombocytopenic Purpura Following Platelet Transfusion: A Clinical Pitfall
Thrombotic thrombocytopenic purpura (TTP) is a rare, life‐threatening thrombotic microangiopathy caused by severe ADAMTS13 deficiency, usually due to autoantibody‐mediated inhibition. Its presentation is heterogeneous and often lacks the classic pentad, leading to diagnostic delays. Neurological symptoms may predominate, masking the underlying hematologic emergency. In our case, a 37‐year‐old previously healthy woman presented with acute headache, speech disturbance, and altered mental status. Despite normal neuroimaging, laboratory tests revealed severe thrombocytopenia and normocytic anemia. Lack of response to erythrocyte and platelet transfusions prompted further evaluation, revealing microangiopathic hemolytic anemia with elevated lactate dehydrogenase, undetectable haptoglobin, indirect hyperbilirubinemia, reticulocytosis, and normal coagulation parameters. A PLASMIC score of 6/7 indicated a high probability of severe ADAMTS13 deficiency. Treatment with high‐dose corticosteroids was initiated immediately, followed by plasma exchange and rituximab. ADAMTS13 activity confirmed severe deficiency at 0.3%, supporting the diagnosis of acquired TTP in the clinical context. The patient achieved rapid remission and complete neurological recovery. This case highlights the importance of early recognition of microangiopathic hemolysis and prompt treatment without waiting for confirmatory ADAMTS13 results to reduce morbidity and mortality.
- Open Access
- 6 July 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0352980
Development and internal validation of an early inpatient risk score for in-hospital mortality in acute pancreatitis: A retrospective cohort study
Introduction: Early identification of patients at high risk of mortality remains a clinical challenge in acute pancreatitis. Existing prognostic tools are often complex or require repeated assessments, limiting their routine use. We aimed to develop and internally validate an early admission-phase risk score for predicting in-hospital mortality in patients with acute pancreatitis. Methods: We conducted a retrospective cohort study of consecutive adult patients admitted with acute pancreatitis between 2020 and 2024. Acute pancreatitis was defined according to the revised Atlanta criteria. Multivariable logistic regression was used to develop a prediction model for in-hospital mortality using routinely available demographic, clinical, and laboratory variables obtained within the first 24 hours of hospitalization. Missing data were handled using multiple imputation. Model performance was assessed by discrimination and calibration, with internal validation performed using bootstrap resampling and temporal validation conducted in patients admitted during 2023–2024. Results: A total of 1,041 patients were included, of whom 53 (5.1%) died during hospitalization. The final model incorporated age, early multi-organ dysfunction within 24 hours of admission, C-reactive protein, and urea levels. The model showed good discrimination (area under the receiver operating characteristic curve, 0.81) and good agreement between predicted and observed in-hospital mortality probabilities. Bootstrap internal validation showed minimal optimism, and temporal validation in patients admitted during 2023–2024 confirmed stable model performance. A simplified risk score derived from the model stratified patients into low-to-intermediate-risk and high-risk categories, with substantially higher observed in-hospital mortality in the high-risk group. Conclusions: We developed and internally validated an admission-phase risk score for predicting in-hospital mortality in patients with acute pancreatitis using readily available clinical variables. The proposed score may support early inpatient risk stratification within the first 24 hours of hospitalization. However, external validation in independent cohorts across diverse healthcare settings, patient populations, and pancreatitis etiologies is required before broader clinical application.
- 6 July 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0352980
Open AccessDevelopment and internal validation of an early inpatient risk score for in-hospital mortality in acute pancreatitis: A retrospective cohort study
Introduction: Early identification of patients at high risk of mortality remains a clinical challenge in acute pancreatitis. Existing prognostic tools are often complex or require repeated assessments, limiting their routine use. We aimed to develop and internally validate an early admission-phase risk score for predicting in-hospital mortality in patients with acute pancreatitis. Methods: We conducted a retrospective cohort study of consecutive adult patients admitted with acute pancreatitis between 2020 and 2024. Acute pancreatitis was defined according to the revised Atlanta criteria. Multivariable logistic regression was used to develop a prediction model for in-hospital mortality using routinely available demographic, clinical, and laboratory variables obtained within the first 24 hours of hospitalization. Missing data were handled using multiple imputation. Model performance was assessed by discrimination and calibration, with internal validation performed using bootstrap resampling and temporal validation conducted in patients admitted during 2023–2024. Results: A total of 1,041 patients were included, of whom 53 (5.1%) died during hospitalization. The final model incorporated age, early multi-organ dysfunction within 24 hours of admission, C-reactive protein, and urea levels. The model showed good discrimination (area under the receiver operating characteristic curve, 0.81) and good agreement between predicted and observed in-hospital mortality probabilities. Bootstrap internal validation showed minimal optimism, and temporal validation in patients admitted during 2023–2024 confirmed stable model performance. A simplified risk score derived from the model stratified patients into low-to-intermediate-risk and high-risk categories, with substantially higher observed in-hospital mortality in the high-risk group. Conclusions: We developed and internally validated an admission-phase risk score for predicting in-hospital mortality in patients with acute pancreatitis using readily available clinical variables. The proposed score may support early inpatient risk stratification within the first 24 hours of hospitalization. However, external validation in independent cohorts across diverse healthcare settings, patient populations, and pancreatitis etiologies is required before broader clinical application.
- Open Access
- 4 July 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Ten-year trends in cardiovascular risk factors among patients hospitalised with acute myocardial infarction in Estonia: a retrospective nationwide observational study
Cardiovascular risk-factor profiles among patients hospitalised with acute myocardial infarction (AMI) can inform surveillance of a high-risk clinical cohort, but do not directly represent risk-factor prevalence in the general population. We analysed aggregate annual Estonian AMI registry data for hospitalised AMI patients during 2015-2024. AMI04 risk-factor trends were assessed using ordinary least squares regression, with sensitivity analyses for known status, age-sex standardisation to the pooled hospitalised AMI cohort, COVID-period exclusion, AMI case mix, and national hospitalised AMI burden. Documented smoking increased from 25.5% in 2015 to 28.1% in 2024 (β = 0.302% points/year; 95% CI 0.014 to 0.590; p = 0.042). The smoking trend remained significant in known-status analyses and after age-sex standardisation, although the crude observed trend became borderline after excluding 2020-2021. Documented dyslipidaemia increased descriptively, but full-period crude and age-sex-standardised trends were borderline, and unknown dyslipidaemia status decreased over time. Annual AMI attacks and national hospitalised AMI burden declined, with concurrent changes in sex and age composition. Among hospitalised AMI patients in Estonia, documented smoking increased during 2015-2024 and remained consistent in known-status and age-sex-standardised sensitivity analyses. Dyslipidaemia trends require cautious interpretation because unknown status changed over time. These aggregate registry findings describe a selected hospitalised AMI cohort and should not be interpreted as direct evidence of national prevention-policy success or failure.
- 4 July 2026
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Open AccessTen-year trends in cardiovascular risk factors among patients hospitalised with acute myocardial infarction in Estonia: a retrospective nationwide observational study
Cardiovascular risk-factor profiles among patients hospitalised with acute myocardial infarction (AMI) can inform surveillance of a high-risk clinical cohort, but do not directly represent risk-factor prevalence in the general population. We analysed aggregate annual Estonian AMI registry data for hospitalised AMI patients during 2015-2024. AMI04 risk-factor trends were assessed using ordinary least squares regression, with sensitivity analyses for known status, age-sex standardisation to the pooled hospitalised AMI cohort, COVID-period exclusion, AMI case mix, and national hospitalised AMI burden. Documented smoking increased from 25.5% in 2015 to 28.1% in 2024 (β = 0.302% points/year; 95% CI 0.014 to 0.590; p = 0.042). The smoking trend remained significant in known-status analyses and after age-sex standardisation, although the crude observed trend became borderline after excluding 2020-2021. Documented dyslipidaemia increased descriptively, but full-period crude and age-sex-standardised trends were borderline, and unknown dyslipidaemia status decreased over time. Annual AMI attacks and national hospitalised AMI burden declined, with concurrent changes in sex and age composition. Among hospitalised AMI patients in Estonia, documented smoking increased during 2015-2024 and remained consistent in known-status and age-sex-standardised sensitivity analyses. Dyslipidaemia trends require cautious interpretation because unknown status changed over time. These aggregate registry findings describe a selected hospitalised AMI cohort and should not be interpreted as direct evidence of national prevention-policy success or failure.
- Open Access
- 27 June 2026
- Published by Springer Nature in BMC Gastroenterology
- Vol. 26 (1)
Clinical characteristics, etiology, and outcomes of acute pancreatitis at a tertiary referral center in Latvia: a retrospective cohort study
Background: Acute pancreatitis is a common cause of gastrointestinal hospitalization, but detailed clinical cohort data from the Baltic region are limited. We aimed to characterize the clinical features, etiologies, comorbidities, and in-hospital outcomes of acute pancreatitis at a tertiary-center in Latvia. Methods: We conducted a retrospective single-center cohort study of adults hospitalized with acute pancreatitis between 2020 and 2024, including only the index admission for each patient. Cases were identified using ICD-10 codes and confirmed according to the Revised Atlanta Classification. Demographic characteristics, etiologic factors, comorbidities, and clinical outcomes were analyzed. Multivariable logistic regression was used to identify factors independently associated with in-hospital complications. Results: A total of 1,047 patients were included; the median age was 50 years (interquartile range, IQR 39–64.5), and 62.0% were male. Alcohol-related pancreatitis was the most common etiology (37.0%), followed by gallstone pancreatitis (24.7%). Overall, 215 patients (20.5%) developed at least one in-hospital complication. In multivariable analysis, alcohol-related pancreatitis (Odds ratio, OR 2.63, 95% Confidence interval, CI 1.59–4.36) and other etiologies (OR 2.89, 95% CI 1.79–4.65) were associated with higher odds of complications than gallstone pancreatitis. Diabetes mellitus (OR 1.69, 95% CI 1.10–2.56) and heart failure (OR 1.70, 95% CI 1.01–2.86) were also associated with increased risk. Median length of hospital stay was 6 days (IQR 4–9), intensive care unit admission occurred in 1.4% of patients, and in-hospital mortality was 5.3%. Conclusions: In this tertiary-center cohort, alcohol-related pancreatitis predominated and was associated with higher odds of the composite in-hospital complication endpoint than gallstone pancreatitis. These findings suggest a region-specific etiologic pattern and indicate that alcohol-related disease may contribute substantially to the acute pancreatitis case burden and adverse in-hospital outcomes in this setting.
- 27 June 2026
- Published by Springer Nature in BMC Gastroenterology
- Vol. 26 (1)
Open AccessClinical characteristics, etiology, and outcomes of acute pancreatitis at a tertiary referral center in Latvia: a retrospective cohort study
Background: Acute pancreatitis is a common cause of gastrointestinal hospitalization, but detailed clinical cohort data from the Baltic region are limited. We aimed to characterize the clinical features, etiologies, comorbidities, and in-hospital outcomes of acute pancreatitis at a tertiary-center in Latvia. Methods: We conducted a retrospective single-center cohort study of adults hospitalized with acute pancreatitis between 2020 and 2024, including only the index admission for each patient. Cases were identified using ICD-10 codes and confirmed according to the Revised Atlanta Classification. Demographic characteristics, etiologic factors, comorbidities, and clinical outcomes were analyzed. Multivariable logistic regression was used to identify factors independently associated with in-hospital complications. Results: A total of 1,047 patients were included; the median age was 50 years (interquartile range, IQR 39–64.5), and 62.0% were male. Alcohol-related pancreatitis was the most common etiology (37.0%), followed by gallstone pancreatitis (24.7%). Overall, 215 patients (20.5%) developed at least one in-hospital complication. In multivariable analysis, alcohol-related pancreatitis (Odds ratio, OR 2.63, 95% Confidence interval, CI 1.59–4.36) and other etiologies (OR 2.89, 95% CI 1.79–4.65) were associated with higher odds of complications than gallstone pancreatitis. Diabetes mellitus (OR 1.69, 95% CI 1.10–2.56) and heart failure (OR 1.70, 95% CI 1.01–2.86) were also associated with increased risk. Median length of hospital stay was 6 days (IQR 4–9), intensive care unit admission occurred in 1.4% of patients, and in-hospital mortality was 5.3%. Conclusions: In this tertiary-center cohort, alcohol-related pancreatitis predominated and was associated with higher odds of the composite in-hospital complication endpoint than gallstone pancreatitis. These findings suggest a region-specific etiologic pattern and indicate that alcohol-related disease may contribute substantially to the acute pancreatitis case burden and adverse in-hospital outcomes in this setting.
- Open Access
- 18 March 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (3) , e0345328
Seasonal variation in hospitalizations for peptic ulcer disease: A five-year retrospective study from Latvia
Peptic ulcer disease (PUD) remains a significant global health burden, yet data on seasonal variations in PUD hospitalizations are inconsistent across regions. No studies have assessed seasonal patterns in PUD hospitalizations in Latvia or the broader Baltic region. This study aimed to evaluate whether seasonal factors influence PUD hospitalizations in this temperate-climate setting. We conducted a retrospective cohort study of adult hospitalizations with a primary discharge diagnosis of PUD (ICD-10 codes K25–K28) from 2020 to 2024 at a tertiary care hospital in Riga, Latvia. Seasonal distribution, ulcer subtype, bleeding status, length of stay (LOS), and in-hospital mortality were analyzed using chi-square, Mann–Whitney U, and Kruskal–Wallis tests, as appropriate. Multivariable logistic regression was performed to assess independent predictors of in-hospital mortality. A total of 606 hospitalizations were analyzed (median age: 66 years; 59.1% male). The median LOS was 6 days. Older adults (≥65 years) had higher in-hospital mortality compared with those <65 years (11.7% vs. 3.5%, representing an absolute difference of 8.2%). Seasonal distribution was relatively even: 22.4% in winter, 23.4% in spring, 30.4% in summer, and 23.8% in fall, with a maximum absolute difference of 8.0% between peak and trough seasons; no significant seasonal differences were observed in demographic or clinical characteristics. In multivariable analysis, season was not independently associated with in-hospital mortality (overall Wald p = 0.952), whereas increasing age was independently associated with mortality (adjusted odds ratio [aOR] 1.04 per year; 95% CI 1.02–1.07; p < 0.001). This study provides the first regional evidence from the Baltic area suggesting that seasonal climatic variation does not substantially influence severe PUD hospitalization patterns within a centralized European healthcare system.
- 18 March 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (3) , e0345328
Open AccessSeasonal variation in hospitalizations for peptic ulcer disease: A five-year retrospective study from Latvia
Peptic ulcer disease (PUD) remains a significant global health burden, yet data on seasonal variations in PUD hospitalizations are inconsistent across regions. No studies have assessed seasonal patterns in PUD hospitalizations in Latvia or the broader Baltic region. This study aimed to evaluate whether seasonal factors influence PUD hospitalizations in this temperate-climate setting. We conducted a retrospective cohort study of adult hospitalizations with a primary discharge diagnosis of PUD (ICD-10 codes K25–K28) from 2020 to 2024 at a tertiary care hospital in Riga, Latvia. Seasonal distribution, ulcer subtype, bleeding status, length of stay (LOS), and in-hospital mortality were analyzed using chi-square, Mann–Whitney U, and Kruskal–Wallis tests, as appropriate. Multivariable logistic regression was performed to assess independent predictors of in-hospital mortality. A total of 606 hospitalizations were analyzed (median age: 66 years; 59.1% male). The median LOS was 6 days. Older adults (≥65 years) had higher in-hospital mortality compared with those <65 years (11.7% vs. 3.5%, representing an absolute difference of 8.2%). Seasonal distribution was relatively even: 22.4% in winter, 23.4% in spring, 30.4% in summer, and 23.8% in fall, with a maximum absolute difference of 8.0% between peak and trough seasons; no significant seasonal differences were observed in demographic or clinical characteristics. In multivariable analysis, season was not independently associated with in-hospital mortality (overall Wald p = 0.952), whereas increasing age was independently associated with mortality (adjusted odds ratio [aOR] 1.04 per year; 95% CI 1.02–1.07; p < 0.001). This study provides the first regional evidence from the Baltic area suggesting that seasonal climatic variation does not substantially influence severe PUD hospitalization patterns within a centralized European healthcare system.